BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10775994)

  • 1. The application of three-dimensional ultrasound to nuchal translucency measurement in early pregnancy (10-14 weeks): a preliminary study.
    Chung BL; Kim HJ; Lee KH
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):122-5. PubMed ID: 10775994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional transvaginal ultrasound improves measurement of nuchal translucency.
    Kurjak A; Kupesic S; Ivancić-Kosuta M
    J Perinat Med; 1999; 27(2):97-102. PubMed ID: 10379497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-to-on versus on-to-out nuchal translucency measurements.
    Herman A; Dreazen E; Samandarov A; Bukovsky Y; Weinraub Z; Maymon R
    Ultrasound Obstet Gynecol; 2000 Feb; 15(2):126-30. PubMed ID: 10775995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between two- and three-dimensional ultrasound measurements of nuchal translucency.
    Clementschitsch G; Hasenöhrl G; Schaffer H; Steiner H
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):475-80. PubMed ID: 11844167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of measurement of fetal nuchal translucency thickness.
    Pandya PP; Altman DG; Brizot ML; Pettersen H; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 May; 5(5):334-7. PubMed ID: 7614139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuchal translucency measurement--non invasive ultrasound screening for fetal abnormalities. Part I].
    Baś-Budecka E; Suzin J; Lipecka-Kidawska E; Sieroszewski P
    Ginekol Pol; 2004 Mar; 75(3):187-91. PubMed ID: 15181875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for fetal chromosome aberrations. Ultrasonic measurement of nuchal translucency thickness is most efficient].
    Valentin L
    Lakartidningen; 1997 Aug; 94(34):2810-2, 2815-6. PubMed ID: 9303990
    [No Abstract]   [Full Text] [Related]  

  • 14. Semiautomated ultrasonographic measurement of fetal nuchal translucency using a computer software tool.
    Bernardino F; Cardoso R; Montenegro N; Bernardes J; de Sá JM
    Ultrasound Med Biol; 1998 Jan; 24(1):51-4. PubMed ID: 9483771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuchal translucency measurement: training of potential examiners.
    Braithwaite JM; Kadir RA; Pepera TA; Morris RW; Thompson PJ; Economides DL
    Ultrasound Obstet Gynecol; 1996 Sep; 8(3):192-5. PubMed ID: 8915089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nuchal translucency measurement--non invasive ultrasound screening for fetal abnormalities. Part II].
    Sieroszewski P; Baś-Budecka E
    Ginekol Pol; 2004 Mar; 75(3):192-6. PubMed ID: 15181876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Three dimensional sonography in nuchal translucency measurements between 10th and 14th weeks of gestation].
    Czekierdowski A; Chołubek G; Sodowski K; Kotarski J
    Ginekol Pol; 2001 Dec; 72(12):961-7. PubMed ID: 11883252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three- versus two-dimensional ultrasound for nuchal translucency thickness measurements: comparison of feasibility and levels of agreement.
    Eppel W; Worda C; Frigo P; Lee A
    Prenat Diagn; 2001 Jul; 21(7):596-601. PubMed ID: 11494299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
    Paul C; Krampl E; Skentou C; Jurkovic D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):481-4. PubMed ID: 11844168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.